Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Cash from Investing Activities (2024 - 2025)

BioAge Labs (BIOA) has disclosed Cash from Investing Activities for 2 consecutive years, with -$14.4 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 55392.31% to -$14.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$95.2 million through Dec 2025, down 25915.3% year-over-year, with the annual reading at -$95.2 million for FY2025, 25915.3% down from the prior year.
  • Cash from Investing Activities hit -$14.4 million in Q4 2025 for BioAge Labs, down from $12.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $12.8 million in Q3 2025 to a low of -$78.0 million in Q1 2025.